NCT05909488: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II
- State
- Not started
- Phase
- Phase 2 and Phase 3
- People
- 30 planned
- Started
- May 2026
- Primary completion
- Jul 2027
- Arms
- EYESTEM 001-X
- Results
- None posted
- 18 Jun 2023: Trial registered